New gene therapy aims to turn the body against deadly brain cancer
Disease control
Not yet recruiting
This study is testing a new gene therapy called TGX-007 for people with a fast-growing type of brain cancer called glioblastoma. The therapy uses a harmless virus to deliver two treatments directly into the tumor: one to kill cancer cells and another to activate the patient's own…
Phase: PHASE1, PHASE2 • Sponsor: Trogenix ltd • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC